Did you know that Numinus offers scholarships for our Psychedelic-Assisted Therapy Training Programs? Hear from one of our scholarship recipients and graduates, Hajar Massarwah, from Palestine, Israel. Psychedelics are not new to Israel, but Psychedelic-assisted therapy is just beginning to spread around the world. Hajar shares her story with Amanda Giesler, our Head of Training Programs at Numinus, "after a profound experience of a medicine journey...I saw that this kind of healing, I want to bring this back to my homeland, to the Holyland." Learn more about our Certification Pathways and keep scrolling to apply: https://lnkd.in/eFFfEkQp Thank you for sharing your journey with us, Hajar! To apply for yourself, click the link below: https://lnkd.in/eVuDFFbc #psychedelics #israel #PAT #psychedelictherapy #MAPS #numinus #scholorship #training
About us
Connect. Heal. Thrive. At Numinus, we serve the Psychedelic Ecosystem through clinical trials in LSD, MDMA, Ketamine, Psilocybin, and 5MEO-DMT. We have KAT clinics in the US and Canada as well as MAPS Protocol Training to become a Certified Psychedelic Provider for licensed and unlicensed practitioners.
- Website
-
http://numinus.com
External link for Numinus
- Industry
- Wellness and Fitness Services
- Company size
- 201-500 employees
- Headquarters
- Vancouver
- Type
- Public Company
- Founded
- 2019
- Specialties
- Psychedelic-assisted Therapy Training, Ketamine Assisted Therapy Clinics, Clinical Trials , PAT, KAT, Psychedelic Trials, Biotech, and Research
Locations
-
Primary
Vancouver, CA
-
Salt Lake City , Utah, US
-
Toronto, Vancouver, Ottowa, Thunder Bay, Sault Ste. Marie, CA
Employees at Numinus
Updates
-
Mental Hygiene 101 for the Fourth of July: the breath, psychedelics, and self-regulation from Steve Thayer. Reflections from our most recent podcast on Psychedelic Frontiers: Powerful Tools for Good Mental Hygiene https://lnkd.in/eK-RrbmV
-
Sage wisdom from Reid Robison in our Psychedelic Frontiers Podcast on how to approach relationships informed by the therapeutic process. Check out the full episode HERE: Powerful Tools for Good Mental Hygiene. https://lnkd.in/eK-RrbmV
-
If you are considering entering the Psychedelic Ecosystem, check out our checklist. We also reached out to those who are successful in the field to ask them how they feel about getting started and thriving! Thank you, Julia Mirer MD, Kathryn Walker, Michelle Weiner DO, MPH, Stephen Suntala, Shari B Kaplan, LCSW, Ashley Southard and our very own Amanda Giesler, Director of Training. https://lnkd.in/eZH9BDj6 #psychedelics #career #privatepractice #ketamine #numinus #psilocybin #MDMA #MAPS
-
This is our last Info Friday, this June, so don't miss it! Imagine coming back from the July 4th holiday with a game plan to change your career! If you are considering changing your career and becoming a Psychedelic-Assisted Therapist, or you want to work in the industry at large, join us to learn your path to get there!
This content isn’t available here
Access this content and more in the LinkedIn app
-
Numinus is no stranger to advancing wellness, and today, we are proud to announce the acquisition of Medbright AI, which will take us even further. By including the Medbright AI technology, Numinus will eliminate administrative headaches while providing psychedelic-assisted therapy using a methodology that Numinus developed over its years of operating clinics. This is particularly important in the reimbursement process in U.S.-based clinics. This alliance seeks to make therapy more accessible with more therapists able to provide care and not be tied up in administrative tasks. For Numinus, adding a new revenue stream increases our growth potential. Read more below: https://lnkd.in/dskvjNFS #psychedelic #AI #acquisition #PAT #therapy #administration #wellness
-
Licensed professionals, MFTs, LSWs, NPs, MDs, PharmDs, and Psychiatric professionals: Are you seeking to fulfill your CEs and CEUs for the year and be at the cutting edge of Mental Health? Non-licensed professionals seeking to join the Psychedelic Ecosystem? Join us to learn more about the various pathways to work in Psychedelic-Assisted Therapy.
This content isn’t available here
Access this content and more in the LinkedIn app
-
We speak so much about preparation and integration for the participants, but what about the therapists' support? Arthur Lee shares his road to Psychedelic Facilitation well before he came to train with Numinus in our Psychedelic-Assisted Therapy Training Program. "While these powerful and transformative moments certainly occur, there is so much more to the role that I couldn’t fully appreciate until I was in the thick of it." Numinus is building a space for all our graduates to connect, share, and learn from one another, even after their training is over. This space will provide bi-monthly supervision with our own, Dr. Steven Thayer, and other licensed professionals on our team to support your growth and expansion as you find your niche in the Psychedelic Ecosystem. You do not have to navigate this alone; we are with you every step of the way. https://lnkd.in/ekxJb__b #supervisionhours #CE #CEU #therapy #psychedelic #PAT
-
Hey, Intermediate to Advanced Practitioners in the Psychedelic, Therapeutic, or Medical space: Embodied Inquiry is an incredible course for supporting your clients from a Somatic body-based perspective. The next cohort starts July 22nd, 2024! This course offers CE credits! As practitioners, clients often come to you with issues that can not be pinpointed with words and can not be placed into diagnostic criteria, but the client is suffering nonetheless. This course will help you speak a new language and deepen your intuitive understanding of mental, emotional, and physical well-being. Register Here: https://lnkd.in/ehai2NQ5 #somatics #bodytherapy #licencedpractitioners #therapy #psychedelics #advancedtraining #ce
-
From Payton Nyquvest on the recent meeting of the FDA drug advisory committee: "While the decision of the PDAC was not the preferred outcome for many in the mental health care community, considering the dire need for an effective treatment for the millions impacted by PTSD, we understand that they were acting in the best interests of patient safety and quality care. Based on the positive results from Lykos’ Phase 3 trial, we are optimistic that once the PDAC’s concerns are addressed, MDMA-assisted therapy will be made available.” "With several psychedelic compounds in late clinical trial stages, the pipeline of potential mental health treatments remains strong, and we are active with drug developers to advance these emerging treatments and make them available to patients. Our focus remains to continue optimizing our clinic network to increase efficiencies, build visibility, and provide excellent care. while executing our plan to achieve profitability with our existing operations, which were and continue not to be dependent on commercialization of new therapies such as MDMA.” https://bit.ly/3VvDfa2 #psychedelic #mentalhealth #mdma #maps #lykos #FDA #numinus